Lexington, Massachusetts Clinical Trials

A listing of Lexington, Massachusetts clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 9 clinical trials
Cookie Testing  

Cookie Testing

Online studies
Site
(online study)
  • 0 views
  • 19 Feb, 2024
  • 1 location
  • Online study
RJ_StudyVirtualF  

Acne

Online studies
Site1_RJ_StudyVirtual1N
(online study)
  • 0 views
  • 19 Feb, 2024
  • 1 location
  • Online study
T2

we

Online studies
8260013
(online study) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
  • Online study
A Multinational Randomized Double-blind Placebo-controlled Study to Assess the Efficacy Pharmacodynamics Pharmacokinetics and Safety of Venglustat in Late-onset GM2

Primary Objectives: Primary population (adult participants with late-onset GM2 gangliosidosis): To assess the efficacy and pharmacodynamics (PD) of daily oral dosing of venglustat when administered over a 104-week period Secondary population (participants with juvenile/adolescent late-onset GM2 gangliosidosis, GM1 gangliosidosis, saposin C deficiency, sialidosis type 1 or juvenile/adult galactosialidosis): To assess …

Investigational Site Number 8400002
 (9.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Prospective Randomized Placebo-Controlled Trial of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE) (SURVIVE)

The primary purpose of this study is to determine whether adding SurVaxM to standard chemotherapy with temozolomide is better than treatment with temozolomide alone for patients with newly diagnosed glioblastoma. This study is designed to compare the duration of survival in patients with newly diagnosed glioblastoma receiving temozolomide plus SurVaxM …

Dana Farber Cancer Institute
 (9.5 away) Contact site
  • 0 views
  • 02 Dec, 2024
  • +9 other locations
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The …

eliglustat
deficiency
imiglucerase
gaucher disease
Investigational Site Number 840062
 (9.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +208 other locations
Mucopolysaccharidosis I (MPS I) Registry

The Mucopolysaccharidosis I (MPS I) Registry is an ongoing, observational database that tracks the outcomes of patients with MPS I. The data collected by the MPS I Registry will provide information to better characterize the natural history and progression of MPS I as well as the clinical responses of patients …

Investigational Site Number 840062
 (9.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +124 other locations
Pompe Disease Registry

The Pompe Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Pompe disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The objectives …

gaa gene
replacement therapy
myozyme
deficiency
glycogen storage disease type ii
Investigational Site Number 840062
 (9.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +168 other locations
Fabry Disease Registry & Pregnancy Sub-registry

The Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The primary …

replacement therapy
fabrazyme
deficiency
agalsidase beta
alpha-galactosidase
Investigational Site Number 840062
 (9.9 away) Contact site
  • 0 views
  • 05 Aug, 2024
  • +125 other locations